Delivery Order SPE2DB20D1047-SPE2DB25FF61U
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a firm fixed price of $2,752.23 and a performance period ending on June 9, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $2,967.00 and a completion date of July 10, 2025. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.35, is for the delivery of the drug PEGASYS 180 MCG/ML VIALML. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at $999,999,999.00, which provides comprehensive global...
This is a $2,782.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, with a period of performance through May 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and is a critical supplier of medical and pharmaceutical products to federal...
This federal contract award, valued at $3,598.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, with a completion date of May 20, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order valued at $2,661.36 for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, with a completion date of May 21, 2024. The contract is Firm Fixed Price and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.32 firm fixed-price delivery order is for the supply of PEGASYS 180 MCG/ML VIALML, a specialty medication. The contract has an ultimate completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract covers the delivery of PEGASYS 180 MCG/ML VIALML, a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 firm fixed-price contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product. The contract has a period of performance through March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $5,236.15 and a period of performance ending on May 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp...